Abemaciclib is used to treat HR-positive and HER2-negative breast cancer in adults. It is a targeted treatment, not a chemotherapy drug (see Is Verzenio (abemaciclib) a chemo drug?).
Abemaciclib (brand name Verzenio) first gained FDA approval on September 28, 2017. There is no generic Verzenio.
